Antidrug Antibodies in Patients Treated with Alirocumab

被引：71

作者：

Roth, Eli M. ^{[1
]}

Goldberg, Anne C. ^{[2
]}

Catapano, Alberico L. ^{[3
]}

Torri, Albert ^{[4
]}

Yancopoulos, George D. ^{[4
]}

Stahl, Neil ^{[4
]}

Brunet, Aurelie ^{[5
]}

Lecorps, Guillaume ^{[6
]}

Colhoun, Helen M. ^{[7
]}

机构：

[1] Sterling Res Grp, Cincinnati, OH 45219 USA

[2] Washington Univ, Sch Med, St Louis, MO USA

[3] Univ Milan, Multimed IRCCS, Milan, Italy

[4] Regeneron Pharmaceut, Tarrytown, NY USA

[5] Sanofi, Bridgewater, NJ USA

[6] Sanofi, Chilly Mazarin, France

[7] Univ Edinburgh, Edinburgh, Midlothian, Scotland

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 16期

关键词：

HYPERCHOLESTEROLEMIA; TRIAL;

D O I：

10.1056/NEJMc1616623

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1589 / 1590

页数：2

共 5 条

[1]

[Anonymous], 2016, FED REGISTER, V81, P24106

[2] Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial [J].

Bays, Harold ;

Gaudet, Daniel ;

Weiss, Robert ;

Ruiz, Juan Lima ;

Watts, Gerald F. ;

Gouni-Berthold, Ioanna ;

Robinson, Jennifer ;

Zhao, Jian ;

Hanotin, Corinne ;

Donahue, Stephen .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (08) :3140-3148

[3] ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia [J].

Kastelein, John J. P. ;

Ginsberg, Henry N. ;

Langslet, Gisle ;

Hovingh, G. Kees ;

Ceska, Richard ;

Dufour, Robert ;

Blom, Dirk ;

Civeira, Fernando ;

Krempf, Michel ;

Lorenzato, Christelle ;

Zhao, Jian ;

Pordy, Robert ;

Baccara-Dinet, Marie T. ;

Gipe, Daniel A. ;

Geiger, Mary Jane ;

Farnier, Michel .

EUROPEAN HEART JOURNAL, 2015, 36 (43) :2996-3003

[4] Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab [J].

Ridker, Paul M. ;

Tardif, Jean-Claude ;

Amarenco, Pierre ;

Duggan, William ;

Glynn, Robert J. ;

Jukema, J. Wouter ;

Kastelein, John J. P. ;

Kim, Albert M. ;

Koenig, Wolfgang ;

Nissen, Steven ;

Revkin, James ;

Rose, Lynda M. ;

Santos, Raul D. ;

Schwartz, Pamela F. ;

Shear, Charles L. ;

Yunis, Carla .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (16) :1517-1526

[5] Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24 week, double-blind, randomized Phase 3 trial [J].

Roth, Eli M. ;

Taskinen, Marja-Riitta ;

Ginsberg, Henry N. ;

Kastelein, John J. P. ;

Colhoun, Helen M. ;

Robinson, Jennifer G. ;

Merlet, Laurence ;

Pordy, Robert ;

Baccara-Dinet, Marie T. .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (01) :55-61

← 1 →